These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9421375

  • 21. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
    Høy M, Olsen HL, Andersen HS, Bokvist K, Buschard K, Hansen J, Jacobsen P, Petersen JS, Rorsman P, Gromada J.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):213-21. PubMed ID: 12679159
    [Abstract] [Full Text] [Related]

  • 22. Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors.
    Ma X, Zhang Y, Gromada J, Sewing S, Berggren PO, Buschard K, Salehi A, Vikman J, Rorsman P, Eliasson L.
    Mol Endocrinol; 2005 Jan 11; 19(1):198-212. PubMed ID: 15459251
    [Abstract] [Full Text] [Related]

  • 23. Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels.
    Gromada J, Bokvist K, Ding WG, Barg S, Buschard K, Renström E, Rorsman P.
    J Gen Physiol; 1997 Sep 11; 110(3):217-28. PubMed ID: 9276750
    [Abstract] [Full Text] [Related]

  • 24. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
    Holz GG.
    Horm Metab Res; 2004 Sep 11; 36(11-12):787-94. PubMed ID: 15655710
    [Abstract] [Full Text] [Related]

  • 25. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA, O'Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR.
    Diabetologia; 2003 Feb 11; 46(2):222-30. PubMed ID: 12627321
    [Abstract] [Full Text] [Related]

  • 26. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
    Nakazaki M, Crane A, Hu M, Seghers V, Ullrich S, Aguilar-Bryan L, Bryan J.
    Diabetes; 2002 Dec 11; 51(12):3440-9. PubMed ID: 12453898
    [Abstract] [Full Text] [Related]

  • 27. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F.
    Diabetes; 1996 Feb 11; 45(2):257-61. PubMed ID: 8549871
    [Abstract] [Full Text] [Related]

  • 28. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
    Flamez D, Gilon P, Moens K, Van Breusegem A, Delmeire D, Scrocchi LA, Henquin JC, Drucker DJ, Schuit F.
    Diabetes; 1999 Oct 11; 48(10):1979-86. PubMed ID: 10512362
    [Abstract] [Full Text] [Related]

  • 29. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells.
    Renström E, Eliasson L, Rorsman P.
    J Physiol; 1997 Jul 01; 502 ( Pt 1)(Pt 1):105-18. PubMed ID: 9234200
    [Abstract] [Full Text] [Related]

  • 30. cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets.
    Yajima H, Komatsu M, Schermerhorn T, Aizawa T, Kaneko T, Nagai M, Sharp GW, Hashizume K.
    Diabetes; 1999 May 01; 48(5):1006-12. PubMed ID: 10331404
    [Abstract] [Full Text] [Related]

  • 31. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr 01; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1.
    Holz GG, Leech CA, Habener JF.
    J Biol Chem; 1995 Jul 28; 270(30):17749-57. PubMed ID: 7543091
    [Abstract] [Full Text] [Related]

  • 34. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
    Holz GG, Leech CA, Heller RS, Castonguay M, Habener JF.
    J Biol Chem; 1999 May 14; 274(20):14147-56. PubMed ID: 10318832
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Watanabe Y, Yamashita K.
    Metabolism; 1992 Apr 14; 41(4):359-63. PubMed ID: 1556941
    [Abstract] [Full Text] [Related]

  • 37. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C, Egan JM, Roth J.
    Endocrinology; 1994 Aug 14; 135(2):589-94. PubMed ID: 8033807
    [Abstract] [Full Text] [Related]

  • 38. A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis.
    Kim SJ, Choi WS, Han JS, Warnock G, Fedida D, McIntosh CH.
    J Biol Chem; 2005 Aug 05; 280(31):28692-700. PubMed ID: 15955806
    [Abstract] [Full Text] [Related]

  • 39. Glucose dependence of insulinotropic actions of pituitary adenylate cyclase-activating polypeptide in insulin-secreting INS-1 cells.
    Rosengren A, Filipsson K, Jing XJ, Reimer MK, Renström E.
    Pflugers Arch; 2002 Jul 05; 444(4):556-67. PubMed ID: 12136276
    [Abstract] [Full Text] [Related]

  • 40. Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells.
    Fridolf T, Ahrén B.
    Mol Cell Endocrinol; 1993 Oct 05; 96(1-2):85-90. PubMed ID: 8276143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.